CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION
A cerebrospinal fluid (CSF) shunt system is used for treatment of hydrocephalus and abnormal intracranial pressure (ICP) conditions. Mostly a shunt system is placed under skin for creating a low resistance pathway between intracranial space and appropriate discharge sites within body by doing so exc...
Other Authors: | |
---|---|
Format: | Others |
Language: | English |
Published: |
Florida Atlantic University
|
Subjects: | |
Online Access: | http://purl.flvc.org/fau/fd/FA00013489 |
id |
ndltd-fau.edu-oai-fau.digital.flvc.org-fau_42638 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-fau.edu-oai-fau.digital.flvc.org-fau_426382020-07-30T05:04:08Z CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION FA00013489 Mutlu, Caner (author) Asghar, Waseem (Thesis advisor) Florida Atlantic University (Degree grantor) Department of Computer and Electrical Engineering and Computer Science College of Engineering and Computer Science 97 p. application/pdf Electronic Thesis or Dissertation Text English A cerebrospinal fluid (CSF) shunt system is used for treatment of hydrocephalus and abnormal intracranial pressure (ICP) conditions. Mostly a shunt system is placed under skin for creating a low resistance pathway between intracranial space and appropriate discharge sites within body by doing so excess CSF volume can exit the intracranial space. Displaced intracranial CSF volume normally results in lowered ICP. Thereby, a CSF shunt can manage ICP. In a healthy person, normal ICP is primarily maintained by CSF production and reabsorption rate as a natural tendency of body. If intracranial CSF volume starts increasing due to under reabsorption, this mostly results in raised ICP. Abnormal ICP can be treated by discharging excess CSF volume via use of a shunt system. Once a shunt system is placed subcutaneously, a patient is expected to live a normal life. However, shunt failure as well as flow regulatory problems are major issues with current passive shunt systems which leaves patients with serious consequences of under-/over CSF drainage condition. In this research, a shunt system is developed which is resistant to most shunt-related causes of under-/over CSF drainage. This has been made possible via use of an on-board medical monitoring (diagnostic) and active flow control mechanism. The developed shunt system, in this research, has full external ventricular drainage (EVD) capability. Further miniaturization will make it possible for an implantable shunt. Florida Atlantic University Cerebrospinal Fluid Shunts Includes bibliography. Thesis (M.S.)--Florida Atlantic University, 2020. FAU Electronic Theses and Dissertations Collection Copyright © is held by the author with permission granted to Florida Atlantic University to digitize, archive and distribute this item for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires permission of the copyright holder. http://rightsstatements.org/vocab/InC/1.0/ http://purl.flvc.org/fau/fd/FA00013489 https://fau.digital.flvc.org/islandora/object/fau%3A42638/datastream/TN/view/CEREBROSPINAL%20FLUID%20SHUNT%20SYSTEM%20WITH%20AUTO-FLOW%20REGULATION.jpg |
collection |
NDLTD |
language |
English |
format |
Others
|
sources |
NDLTD |
topic |
Cerebrospinal Fluid Shunts |
spellingShingle |
Cerebrospinal Fluid Shunts CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION |
description |
A cerebrospinal fluid (CSF) shunt system is used for treatment of hydrocephalus and abnormal intracranial pressure (ICP) conditions. Mostly a shunt system is placed under skin for creating a low resistance pathway between intracranial space and appropriate discharge sites within body by doing so excess CSF volume can exit the intracranial space. Displaced intracranial CSF volume normally results in lowered ICP. Thereby, a CSF shunt can manage ICP. In a healthy person, normal ICP is primarily maintained by CSF production and reabsorption rate as a natural tendency of body. If intracranial CSF volume starts increasing due to under reabsorption, this mostly results in raised ICP. Abnormal ICP can be treated by discharging excess CSF volume via use of a shunt system. Once a shunt system is placed subcutaneously, a patient is expected to live a normal life. However, shunt failure as well as flow regulatory problems are major issues with current passive shunt systems which leaves patients with serious consequences of under-/over CSF drainage condition. In this research, a shunt system is developed which is resistant to most shunt-related causes of under-/over CSF drainage. This has been made possible via use of an on-board medical monitoring (diagnostic) and active flow control mechanism. The developed shunt system, in this research, has full external ventricular drainage (EVD) capability. Further miniaturization will make it possible for an implantable shunt. === Includes bibliography. === Thesis (M.S.)--Florida Atlantic University, 2020. === FAU Electronic Theses and Dissertations Collection |
author2 |
Mutlu, Caner (author) |
author_facet |
Mutlu, Caner (author) |
title |
CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION |
title_short |
CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION |
title_full |
CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION |
title_fullStr |
CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION |
title_full_unstemmed |
CEREBROSPINAL FLUID SHUNT SYSTEM WITH AUTO-FLOW REGULATION |
title_sort |
cerebrospinal fluid shunt system with auto-flow regulation |
publisher |
Florida Atlantic University |
url |
http://purl.flvc.org/fau/fd/FA00013489 |
_version_ |
1719334216756363264 |